🎉 Milestone update for the EN.10 trial The EN.10 trial has reached an important milestone, with the accrual target for Sub-study B/TAPER now achieved. A total of 180 participants have been enrolled, and recruitment to Sub-study B/TAPER has officially closed. This achievement reflects the dedication of investigators, research teams, and participants across Australia and New Zealand. Thank you to everyone who has contributed to making this milestone possible. While recruitment to TAPER has closed, Sub-study A/RAINBO BLUE remains open, and we encourage sites across Australia and New Zealand to continue screening and enrolling eligible participants. Every participant recruited brings researchers one step closer to improving treatment options and outcomes for women with endometrial cancer. Thank you to all investigators, site staff, and most importantly, the participants who continue to support this important international clinical trial. #ANZGOG #ClinicalTrials #EndometrialCancer #CancerResearch #EN10 #TAPER #RAINBOBLUE

📢 Registrations are now open for the ANZGOG 2027 Annual Scientific Meeting. Join international and local leaders in gynaecological cancer research, treatment and care in Adelaide from 21-23 April 2027 for ANZGOG's 27th Annual Scientific Meeting. Under the theme "The Collective Leap: United Action in Gynaecological Cancer", the ASM will bring together researchers, clinicians, allied health professionals, lived experience advocates and industry partners to explore emerging evidence, strengthen collaborations and drive better outcomes for women with gynaecological cancers. We're delighted to welcome international keynote speakers: 🔹 Dr Stephanie Lheureux (Canada) 🔹 Dr Anisa Mburu (Kenya) 🔹 Professor Remi Nout (The Netherlands) Featuring keynote presentations, the Pure Science Symposium and dedicated workshops across nursing, radiation oncology, study coordination, gynaecological oncology and early career researcher development. 📍 Adelaide | 21-23 April 2027 🎟️ Register now: anzgogasm.org.au A special thank you to Business Events Adelaide for supporting ANZGOG's 2027 Annual Scientific Meeting. #ANZGOG2027ASM #GynaecologicalCancer #ClinicalResearch #Oncology #WomensHealth #BusinessEventsAdelaide

💜 National Carers Week | 11-17 October This National Carers Week, we're recognising the invaluable contribution of carers who support women facing gynaecological cancer. Whether they're a partner, family member, friend or loved one, carers provide practical support, emotional encouragement and unwavering care through some of life's most challenging moments. This year's theme, "Care for a Carer: Making Carers Visible", encourages us all to acknowledge, support and appreciate the carers in our families, workplaces and communities. To every carer supporting a woman through her gynaecological cancer journey: thank you. Your care makes a difference every day. 💜 Let's take a moment this week to recognise the carers around us and ensure they feel seen, valued and supported. #NationalCarersWeek #CareForACarer #MakingCarersVisible #WomenCan #ANZGOG #GynaecologicalCancer

ANZGOG is pleased to announce the appointment of Professor Paul Cohen as Chair-Elect of the ANZGOG Board of Directors, joining current Chair, Professor Clare Scott AM as part of a planned leadership succession. Professor Scott AM will continue in her role as Chair until the completion of her term in 2027, ensuring strong continuity of governance and strategic direction across ANZGOG's growing research portfolio. A highly respected gynaecological oncologist, researcher and clinical leader, Professor Cohen currently serves as Chair of ANZGOG's Research Advisory Committee and has held numerous leadership roles within the international gynaecological cancer research community. His appointment reflects ANZGOG's commitment to strong governance, leadership continuity, and advancing research that improves outcomes and quality of life for people affected by gynaecological cancers. As Chair-Elect, Professor Cohen will work closely with Professor Scott to support a seamless transition and help guide ANZGOG's next chapter of growth and impact. Please join us in congratulating Professor Cohen on this appointment. 👏 Read the full announcement: anzgog.org.au/professor-paul…

Congratulations to our Manager of Research Programs & Pipeline, John Andrews, ANZGOG Member Linda Mileshkin and Yeh Chen Lee on their contribution as co-authors of the recently published paper, Pragmatic gynecologic cancer clinical trials: statements and roadmap from the Gynecologic Cancer InterGroup Chicago Brainstorming Meeting, published in the International Journal of Gynecological Cancer. Bringing together international expertise, the publication outlines a roadmap for advancing pragmatic clinical trials in gynaecological cancers, helping to ensure research is more accessible, efficient and reflective of real-world patient care. We're proud of their important contribution to global efforts to strengthen clinical research and improve outcomes for women facing gynaecological cancers. 💜 🔗 Read the publication: sciencedirect.com/science/ar…

💜 This Menopause Awareness Month, we're highlighting the importance of information, care and support for women experiencing medical menopause. Menopause doesn't always happen at midlife. For some women, it begins suddenly as a result of cancer treatment or risk-reducing surgery. At ANZGOG's recent National Gynaecological Cancer Priorities Roundtable, discussions highlighted a significant concern for women with a gynaecological cancer, including those who are diagnosed at a young age or with a high inherited risk of cancer: uncertainty about menopause care can become a barrier to treatment and risk-reducing surgery. ANZGOG-supported research, including the WHAM (What Happens After Menopause?) study, is helping improve our understanding of the impact of medically induced menopause on quality of life, including sleep, mood, sexual wellbeing and overall health. By supporting research, we're helping generate the evidence needed to improve care, support informed decision-making and ensure women have access to the right information and support throughout treatment and beyond. Women experiencing medical menopause following cancer treatment need continuity of care, with access to trusted information, evidence-based care and appropriate support throughout their journey. Let's make conversations about medical menopause part of routine care, so every woman feels informed, supported and empowered to make the decisions that are right for her. 💜 🔗 Learn more about the WHAM study anzgog.org.au/principle-inve… #WorldMenopauseMonth #MenopauseAwareness #WomensHealth #GynaecologicalCancer #WomenCan #ANZGOG

📣 Applications for ANZGOG's Online Preceptorship 2026 on Ovarian Cancer are closing soon. We've extended the application deadline to Monday 5 October 2026, giving aspiring Fellows, Trainees, Registrars, early career clinicians and nurses a few extra days to apply. This unique mentoring and educational opportunity connects participants with leading experts in ovarian cancer care and research, providing valuable insights, networking opportunities and the chance to present on an assigned topic. ⏰ Applications now close 5 October 2026 📅 Friday 20 November 2026 | 12.00pm - 5.00pm AEDT 📅 Saturday 21 November 2026 | 10.30am - 12.40pm AEDT 📌 Registrations to attend the Preceptorship will open later in October. 🔗 Find out more and download an application: anzgog.org.au/about/precepto…

💜 Today is World Cancer Research Day. Every breakthrough in gynaecological cancer begins with research. But research doesn't happen alone. This year's theme, Advancing Cancer Research Together, recognises the vital role that researchers, clinicians, people with lived experience, clinical trial participants, advocates and supporters play in driving progress. For more than 25 years, ANZGOG has been conducting world-leading research to find better treatments and improve outcomes for women with gynaecological cancers. Today, our community of more than 1,650 members works together across Australia and New Zealand to advance research and improve the lives of women facing these cancers. That spirit of collaboration was central to the recent National Gynaecological Cancer Roundtable convened by ANZGOG at Parliament House. Members joined leaders from government, research, healthcare, advocacy and lived experience to identify shared priorities for action, including how research can help close gaps in treatment, care and support. We thank the researchers driving discovery, the clinicians delivering innovation, the trial participants helping shape the future of care, and the supporters whose generosity makes progress possible. Together, we're advancing research and saving lives. 💜 #WorldCancerResearchDay #AdvancingCancerResearchTogether #AdvancingResearchSavingLives #GynaecologicalCancerResearch #ClinicalTrials

📢 Final week to apply for ANZGOG's 2026 Fund for New Research Grants. The next breakthrough in gynaecological cancer treatment, prevention or care could start with a research question waiting to be answered. Thanks to the generosity of ANZGOG donors, funding is available across four priority research areas: 🔹 Endometrial cancer focused surgical study – up to $55,000 🔹 Leiomyosarcoma focused project – up to $65,000 🔹 Endometrial cancer focused project – up to $100,000 🔹 Clinical or pre-clinical ovarian carcinosarcoma project – up to $50,000 These grants are designed to support early-stage research, helping investigators test promising concepts, generate new evidence, and build the foundations for future discoveries that improve outcomes for people affected by gynaecological cancers. ⏰ Applications close Monday 28th September. Don't miss the opportunity to bring your research idea to life. 🔗 Learn more and apply: lnkd.in/d7fNmus2 #GynaecologicalCancer #CancerResearch #ResearchFunding #ANZGOG #ClinicalResearch #MedicalResearch

💜 Today is World Gynecologic Oncology Day This year's theme, Support Not Stigma, is a reminder that no one facing a gynaecological cancer should feel alone. More than 3 million women worldwide are living with a gynaecological cancer, and over 1 million are diagnosed each year. Yet stigma, lack of awareness and delayed diagnosis continue to impact outcomes. While overall cancer survival rates in Australia have improved over the past 25 years, survival rates for gynaecological cancers have remained largely unchanged. Greater investment in research is critical to improving outcomes for people affected by these diseases. We're working alongside people with lived experience, researchers, clinicians and advocates to improve treatment, advance research and raise awareness of gynaecological cancers. Together, we can challenge stigma, raise awareness and invest in the research needed to improve outcomes. 👉 Support life-saving research: womencan.org.au/donate #WorldGODay #SupportNotStigma #GynaecologicalCancer

💜 Today is Vulvar Cancer Awareness Day Vulvar cancer is rare, but its impact is significant. Every day, another woman in Australia is diagnosed with vulvar cancer. 📊 The facts: • 427 women are diagnosed with vulvar cancer each year in Australia. • 126 women lose their lives to the disease every year. • More than 1,500 women are currently living with vulvar cancer. • While the five-year survival rate is 74.7%, delays in diagnosis can dramatically reduce survival outcomes. Symptoms can include persistent itching, bleeding, pain or ulcerated lesions. Knowing what is normal for your body—and seeking medical advice when something changes—can support earlier diagnosis. Research is also critical to improving treatment and quality of life. ANZGOG, in partnership with the Canadian Cancer Trials Group, is leading the STRIVE clinical trial in Australia and Aotearoa New Zealand. The international study is investigating how the biology of vulvar squamous cell carcinoma—the most common form of vulvar cancer—can guide more personalised surgical treatment. By examining whether a tumour is HPV-associated or HPV-independent, along with molecular markers such as p53, STRIVE aims to: • Improve surgical decision-making • Reduce the risk of cancer returning • Avoid unnecessary additional surgery and its complications • Strengthen treatment guidelines for vulvar cancer The first Australasian trial site opened at Auckland City Hospital in January 2026 and is actively recruiting eligible participants. On Vulvar Cancer Awareness Day, we recognise everyone affected by this disease and reaffirm our commitment to research that enables women to live better and live longer. 🔗 Learn more about STRIVE: anzgog.org.au/strive-trial/ #VulvarCancerAwarenessDay #VulvarCancer #GynaecologicalCancer #ClinicalTrials #CancerResearch #ANZGOG

Yesterday, more than 40 leaders from government, research, healthcare and the community came together at Australian Parliament House for Australia’s first National Gynaecological Cancer Roundtable. Convened by ANZGOG, the Roundtable was a powerful demonstration of what can be achieved through united action, bringing evidence, expertise and the voices of women with lived experience into the same room to identify how we can accelerate progress in gynaecological cancer. We were pleased to be joined by The Hon Rebecca White MP, Assistant Minister for Women, Assistant Minister for Health and Aged Care, and Assistant Minister for Indigenous Health, who opened and closed the Roundtable and reaffirmed the Australian Government’s commitment to listening to women and improving their health outcomes. With 19 women diagnosed and six dying from a gynaecological cancer every day, and diagnoses projected to rise by 21 per cent over the next decade, the need for action is urgent. Guided by the principles of Equity, Evidence and Enablers, discussions focused on two critical areas: • Prevention and early diagnosis • Living with cancer and care pathways The depth, honesty and generosity of the discussion were extraordinary. We are especially grateful to the women who shared their lived experiences, ensuring that the challenges facing women and their families remained at the centre of every conversation. The Roundtable was an important step in building consensus on the priority actions needed to improve prevention, diagnosis, treatment, care and support. ANZGOG will now work with participants to capture the shared priorities and build a clear pathway to turn them into action. Thank you to Assistant Minister White, all delegates and especially the women with a lived experience who contributed their expertise, experience and commitment to this landmark gathering. United action. Shared priorities. Better outcomes. Caitlin Francis Monique Cerreto Anna Boltong Christine Cockburn Sarah Powell Dorothy Keefe Vivienne Milch Yoland Antill Fiona Webb Tiffany Boughtwood Bronwyn Jennings Karen Canfell AC FAHMS Emma Allanson Anna DeFazio AM Andreas Obermair Kylie Gorringe Haryana Dhillon Ariane Hermann Jo Mond Debbie Shiell Bridget Bradhurst Robin Penty Ovarian Cancer Australia Ovarian Cancer Research Foundation (OCRF) Rare Cancers Australia Cancer Australia #GynaecologicalCancer #WomensHealth #CancerResearch #HealthEquity #LivedExperience #UnitedAction #ANZGOG

📣 Applications are now open for ANZGOG's Online Preceptorship 2026 on Ovarian Cancer Designed for Fellows, Trainees, Registrars, early career clinicians and nurses, this unique educational and mentoring opportunity offers participants the chance to learn from leading experts in ovarian cancer care and research. Facilitated by Prof Kylie Gorringe, A/Prof Rhonda Farrell and Dr Catherine Shannon, and supported by an outstanding Preceptor Panel, the program combines mentorship, practical learning and participant presentations. We are now calling for applications from those interested in being mentored and to present a talk on an assigned topic at the Preceptorship. 📅 Friday 20 November 2026 | 12.00pm - 5.00pm AEDT 📅 Saturday 21 November 2026 | 10.30am - 12.40pm AEDT ⏰ Applications close Thursday 1 October 2026 📌 Registrations to attend the Preceptorship will open later in October. 🔗 Find out more and download an application today anzgog.org.au/about/precepto…

💛 Today is R U OK? Day. A cancer diagnosis doesn't just affect physical health. It can affect every part of a person's life, including their emotional wellbeing. For many people living with gynaecological cancer, the journey can feel overwhelming, isolating and uncertain. A simple check-in can make a meaningful difference. It's also important to remember our medical community, including clinicians, nurses, allied health professionals and researchers who work tirelessly to care for and support people through treatment and beyond. Supporting others every day can take an emotional toll, and they may need a check-in too. If someone is on your mind today, reach out. Ask how they're really doing. Take the time to listen. 💛 Because no one should have to face cancer, or support others through it, alone. #RUOKDay #AreYouOK #GynaecologicalCancer #WomensHealth #ConnectionMatters

Radiotherapy is more than a treatment. It’s a team of highly skilled people working together with precision, expertise and care. Today, on World Radiotherapy Awareness Day, we recognise the vital role radiotherapy plays in the treatment of many gynaecological cancers and the dedicated radiation oncologists, radiation therapists, nurses and wider multidisciplinary teams who make this possible. For those diagnosed with a gynaecological cancer, radiotherapy can be an important part of their treatment, helping to control cancer, reduce the risk of recurrence and, in some circumstances, provide life-prolonging or palliative care. Yet the expertise and complex work behind delivering radiotherapy safely and to the highest possible standard can often go unseen. As an organisation dedicated to improving outcomes for people with gynaecological cancer, ANZGOG recognises the essential contribution of radiation oncology to multidisciplinary cancer care, and the people behind it. Today, we thank the radiation oncology community for the skill, precision and care they bring to every patient’s treatment. Together, through research, collaboration and innovation, we can continue to improve radiotherapy and outcomes for women with gynaecological cancer. #WorldRadiotherapyAwarenessDay #WRAD2026 #Radiotherapy #RadiationOncology #GynaecologicalCancer #CancerResearch #ANZGOG

💜 Women’s Health Week starts tomorrow and it’s especially timely that it falls during Gynaecological Cancer Awareness Month. This year’s theme, “Do It Anyway,” encourages women to take small, achievable steps towards better health. One of the most important steps you can take is advocating for your own health. If you've ever felt unheard, dismissed or uncertain about what to do next, knowing how to speak up and ask questions can make all the difference. 🎧 This Women’s Health Week, and throughout Gynaecological Cancer Awareness Month, we encourage you to listen to On the Down Low — Season 2, Episode 6: Advocacy: What Women Need to Know (From a Patient and Clinician Perspective). #WomensHealthWeek #DoItAnyway #WomensHealth #GynaecologicalCancerAwareness

🎉Milestone update for the EN.10/TAPER trial The EN.10/TAPER trial has reached 20% recruitment in Australia and New Zealand, with 24 participants now enrolled, an important milestone for this international clinical trial. A special acknowledgement to the team at Christchurch Hospital, led by Principal Investigator Bryony Symcock, who have enrolled 7 participants to date. A huge thank you to our most active site, Westmead Hospital (PI – Prof. Alison Brand) who have screened 37 potential participants. Led by Study Chair Professor Alison Brand, EN.10/TAPER is investigating whether treatment can be safely de-escalated for people with POLE-mutated endometrial cancer, with the potential to reduce treatment burden while maintaining effective cancer control. Every participant recruited brings researchers one step closer to answering an important question about how we can deliver more personalised treatment and improve quality of life for people with gynaecological cancer. Thank you to the investigators, research teams and, most importantly, the participants contributing to this important international study. 24 participants. 20% recruited. One step closer to new evidence that could help shape the future of treatment. 🔬 Learn more about the EN.10/TAPER trial: clinicaltrials.gov/study/NCT… #ANZGOG #ClinicalTrials #GynaecologicalCancer #EndometrialCancer #CancerResearch #ClinicalResearch #TAPERTrial #EN10

September is Gynaecological Cancer Awareness Month. Every day, 19 women are diagnosed with a gynaecological cancer and tragically 6 women lose their lives. These are our mothers, daughters, sisters, grandmothers, neighbours and friends. Ovarian, uterine (endometrial), cervical, vulvar and vaginal cancers affect thousands of Australians each year, yet awareness and research funding continue to lag behind many other cancer types. Throughout September, we'll be sharing stories and shining a light on the five gynaecological cancers and the urgent need for greater awareness, earlier detection and better treatment options. 💜 You can make a difference and GO For Gynae this month. Visit womencan.org.au/event/go-for… to learn more. Together, we can help ensure no one faces gynaecological cancer alone. #GCAM2026 #GynaecologicalCancerAwarenessMonth #ANZGOG #AdvancingResearchSavingLives

💡 Got a research idea that could advance gynaecological cancer outcomes? ANZGOG's annual Ideas Generation Workshops provide an opportunity for clinicians and researchers to collaborate, refine ideas, and develop innovative research concepts that could shape future gynaecological cancer research. We're seeking ideas across all areas of gynaecological cancer research, including: ✔️ Prevention ✔️ Treatment ✔️ Translational research ✔️ Quality of life ✔️ Symptom benefit studies Considering submitting an idea? Hear from Dr Niveditha Rajadevan as she shares her experience with ANZGOG's Ideas Generation Workshops and her advice for members thinking about putting an idea forward. ⏰ Only 3 weeks left to submit your idea Ideas Generation Workshops 📅 Friday 16 October 2026 📍 Rydges Airport Hotel, Sydney 📝 Submission deadline: Monday 21 September 2026 Please note: Workshops are open to ANZGOG members only.

Do you know someone whose experience of gynaecological cancer could help shape the future of care? ANZGOG is seeking people with lived experience of gynaecological cancer to join our Survivors Teaching Students® (STS) program. Through STS, volunteers share their experiences directly with medical, nursing and allied health students, offering insights into the realities of recognising symptoms, receiving a diagnosis, navigating treatment, recovery and life beyond cancer. These are lessons that go beyond the textbook, helping future health professionals better understand the person behind the diagnosis. Since launching in Australia in 2017, and expanding to New Zealand in 2021, STS has reached more than 25,000 students, with presentations delivered by 117 volunteers in partnership with 23 universities. Now, we need more voices across: 📍 Western Australia 📍 Tasmania 📍 ACT/Canberra For STS Regional Coordinator and ovarian cancer survivor, Ann Prunty OAM, sharing her story is an opportunity to create a lasting legacy. "Knowing that our experiences may stay with a future doctor or health professional and influence the way they care for women makes volunteering incredibly worthwhile." Do you know someone who could make a lasting impact by sharing their experience? Learn more and register your interest: anzgog.org.au/sts/ #GynaecologicalCancer #MedicalEducation #NursingEducation #LivedExperience #SurvivorsTeachingStudents #HealthcareEducation #ANZGOG